| Extensive stage SCLC (Es-SCLC) | ||
| Extensive stage SCLC (Es-SCLC) - maintenance (M) | Extensive stage SCLC (Es-SCLC) - 1st Line (L1) | |
| anti-PD-(L)1 | ||
| atezolizumab based treatment | ||
| atezolizumab plus SoC | IMpower-133 | |
| durvalumab based treatment | ||
| durvalumab plus etoposide and platin | CASPIAN ... | |
| nivolumab based treatment | ||
| nivolumab alone | CheckMate 451 ... | |
| pembrolizumab based treatment | ||
| pembrolizumab plus SoC | KEYNOTE-604 | |
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
